Universe Pharmaceuticals INC UPC
1.59 USD +0.01 (+0.96%)
Nov 12, 2026, 9:58 AM EST
1.51 Day range 1.59
1.33 52-week range 17.96
- YTD
- -58.40%
- 1 year
- -56.93%
UPC revenue history
Revenue is income from the company’s ordinary business activities.
17,858,732 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-09-30 | 17,858,732 | -5,165,726 | -22.44% |
| FY 2024 | 2024-09-30 | 23,024,458 | -9,284,277 | -28.74% |
| FY 2023 | 2023-09-30 | 32,308,735 | -7,834,416 | -19.52% |
| FY 2022 | 2022-09-30 | 40,143,151 | -7,838,880 | -16.34% |
| FY 2021 | 2021-09-30 | 47,982,031 | 17,278,071 | 56.27% |
| FY 2020 | 2020-09-30 | 30,703,960 | -2,525,356 | -7.60% |
| FY 2019 | 2019-09-30 | 33,229,316 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-09-05T06:02:14.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.